193 related articles for article (PubMed ID: 8613003)
1. Expression of cadherins and alpha-catenin in primary epithelial tumors of the liver.
Kozyraki R; Scoazec JY; Flejou JF; D'Errico A; Bedossa P; Terris B; Fiorentino M; Bringuier AF; Grigioni WF; Feldmann G
Gastroenterology; 1996 Apr; 110(4):1137-49. PubMed ID: 8613003
[TBL] [Abstract][Full Text] [Related]
2. The mode of tumour progression in combined hepatocellular carcinoma and cholangiocarcinoma: an immunohistochemical analysis of E-cadherin, alpha-catenin and beta-catenin.
Asayama Y; Taguchi Ki K; Aishima Si S; Nishi H; Masuda K; Tsuneyoshi M
Liver; 2002 Feb; 22(1):43-50. PubMed ID: 11906618
[TBL] [Abstract][Full Text] [Related]
3. Expression of epithelial cadherin and alpha- and beta-catenins in nontumoral livers and hepatocellular carcinomas.
Ihara A; Koizumi H; Hashizume R; Uchikoshi T
Hepatology; 1996 Jun; 23(6):1441-7. PubMed ID: 8675162
[TBL] [Abstract][Full Text] [Related]
4. N-cadherin serves as diagnostic biomarker in intrahepatic and perihilar cholangiocarcinomas.
Mosnier JF; Kandel C; Cazals-Hatem D; Bou-Hanna C; Gournay J; Jarry A; Laboisse CL
Mod Pathol; 2009 Feb; 22(2):182-90. PubMed ID: 18622386
[TBL] [Abstract][Full Text] [Related]
5. Loss of ezrin in human intrahepatic cholangiocarcinoma is associated with ectopic expression of E-cadherin.
Guedj N; Vaquero J; Clapéron A; Mergey M; Chrétien Y; Paradis V; Fouassier L
Histopathology; 2016 Aug; 69(2):211-21. PubMed ID: 26791814
[TBL] [Abstract][Full Text] [Related]
6. Claudin-7 protein differentiates canine cholangiocarcinoma from hepatocellular carcinoma.
Jakab C; Kiss A; Schaff Z; Szabó Z; Rusvai M; Gálfi P; Szabára A; Sterczer A; Kulka J
Histol Histopathol; 2010 Jul; 25(7):857-64. PubMed ID: 20503174
[TBL] [Abstract][Full Text] [Related]
7. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract.
Riener MO; Vogetseder A; Pestalozzi BC; Clavien PA; Probst-Hensch N; Kristiansen G; Jochum W
Hum Pathol; 2010 Nov; 41(11):1558-65. PubMed ID: 20621328
[TBL] [Abstract][Full Text] [Related]
8. Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.
Endo K; Ueda T; Ueyama J; Ohta T; Terada T
Hum Pathol; 2000 May; 31(5):558-65. PubMed ID: 10836294
[TBL] [Abstract][Full Text] [Related]
9. Significant correlations of E-cadherin, catenin, and CD44 variant form expression with carcinoma cell differentiation and prognosis of extrahepatic bile duct carcinomas.
Mikami T; Saegusa M; Mitomi H; Yanagisawa N; Ichinoe M; Okayasu I
Am J Clin Pathol; 2001 Sep; 116(3):369-76. PubMed ID: 11554165
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin but not N-cadherin expression is correlated with the intracellular distribution of catenins in human hepatocellular carcinomas.
Nuruki K; Toyoyama H; Ueno S; Hamanoue M; Tanabe G; Aikou T; Ozawa M
Oncol Rep; 1998; 5(5):1109-14. PubMed ID: 9683818
[TBL] [Abstract][Full Text] [Related]
11. Cadherin/catenin complex appears to be intact in hepatocellular carcinomas from Australia and South Africa.
Herath NI; Walsh MD; Kew MC; Young J; Leggett BA; Macdonald GA
J Gastroenterol Hepatol; 2004 Jun; 19(6):676-82. PubMed ID: 15151624
[TBL] [Abstract][Full Text] [Related]
12. Expression of E-cadherin, alpha-catenin, beta-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study.
Ashida K; Terada T; Kitamura Y; Kaibara N
Hepatology; 1998 Apr; 27(4):974-82. PubMed ID: 9537436
[TBL] [Abstract][Full Text] [Related]
13. Correlation of aPKC-iota and E-cadherin expression with invasion and prognosis of cholangiocarcinoma.
Li Q; Wang JM; Liu C; Xiao BL; Lu JX; Zou SQ
Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):70-5. PubMed ID: 18234642
[TBL] [Abstract][Full Text] [Related]
14. Expression of E-cadherin, alpha-catenin and beta-catenin in normal ovarian surface epithelium and epithelial ovarian cancers.
Davies BR; Worsley SD; Ponder BA
Histopathology; 1998 Jan; 32(1):69-80. PubMed ID: 9522220
[TBL] [Abstract][Full Text] [Related]
15. [Expression patterns of E-cadherin and beta-catenin according to clinicopathological characteristics of hepatocellular carcinoma].
Bae SH; Jung ES; Park YM; Jang JW; Choi JY; Cho SH; Yoon SK; Ahn BM; Cha SB; Chung KW; Sun HS; Park DH; Kim BK; Kim DG
Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):297-303. PubMed ID: 12499787
[TBL] [Abstract][Full Text] [Related]
16. Expression of E-cadherin and β-catenin in two cholangiocarcinoma cell lines (OZ and HuCCT1) with different degree of invasiveness of the primary tumor.
Abuetabh Y; Persad S; Nagamori S; Huggins J; Al-Bahrani R; Sergi C
Ann Clin Lab Sci; 2011; 41(3):217-23. PubMed ID: 22075503
[TBL] [Abstract][Full Text] [Related]
17. Gross appearance of hepatocellular carcinoma reflects E-cadherin expression and risk of early recurrence after surgical treatment.
Inayoshi J; Ichida T; Sugitani S; Tsuboi Y; Genda T; Honma N; Asakura H
J Gastroenterol Hepatol; 2003 Jun; 18(6):673-7. PubMed ID: 12753149
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA
Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of E-cadherin and I-catenin in human hepatocellular carcinoma cell lines by sodium butyrate and interferon-alpha.
Masuda T; Saito H; Kaneko F; Atsukawa K; Morita M; Inagaki H; Kumagai N; Tsuchimoto K; Ishii AH
In Vitro Cell Dev Biol Anim; 2000 Jun; 36(6):387-94. PubMed ID: 10949998
[TBL] [Abstract][Full Text] [Related]
20. Patterns of alpha- and beta-catenin and E-cadherin expression in colorectal adenomas and carcinomas.
van der Wurff AA; Vermeulen SJ; van der Linden EP; Mareel MM; Bosman FT; Arends JW
J Pathol; 1997 Jul; 182(3):325-30. PubMed ID: 9349236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
